Engaging practices and communities in the development of interventions to promote HPV vaccine uptake: a protocol for implementing Boot Camp Translation in the private practice setting.

Sarah E Brewer, Matthew J Simpson, John D Rice, Amanda Skenadore, Sean T O'Leary
Author Information
  1. Sarah E Brewer: Adult and Child Consortium for Health Outcomes Research and Delivery Sciences (ACCORDS), University of Colorado Anschutz Medical Campus, Aurora, CO, USA sarah.brewer@cuanschutz.edu. ORCID
  2. Matthew J Simpson: Adult and Child Consortium for Health Outcomes Research and Delivery Sciences (ACCORDS), University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  3. John D Rice: Adult and Child Consortium for Health Outcomes Research and Delivery Sciences (ACCORDS), University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  4. Amanda Skenadore: Adult and Child Consortium for Health Outcomes Research and Delivery Sciences (ACCORDS), University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  5. Sean T O'Leary: Adult and Child Consortium for Health Outcomes Research and Delivery Sciences (ACCORDS), University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Abstract

INTRODUCTION: The report states a goal of 80% uptake of recommended vaccines among adolescents, including the human papillomavirus (HPV) vaccine. However, the rate of uptake of the HPV vaccine is estimated at 51% in 2018, which leaves young people vulnerable to morbidity and mortality from preventable, HPV-related cancers. Reasons for this are multifactorial and include factors at the level of the provider, primary care practice, patient and family, and community. The development of interventions that are responsive to these multifactorial barriers in real-world settings is a priority. Boot Camp Translation (BCT) is a community-engaged approach to message development for translating evidence-based practices into clinics and communities. This project aims to (1) Engage practices and communities in the development of interventions to promote HPV vaccine uptake and (2) Evaluate the impact of the BCT-designed intervention on practice-level HPV vaccine initiation rates. We hypothesise that the BCT-designed intervention will increase the rate of HPV vaccine initiation in the practices.
METHODS AND ANALYSIS: This study will implement HPV-focused BCT in three counties in Colorado with a below average county-level vaccination rate. Each BCT group will design a multipronged intervention targeted at patients, parents, providers and the general community to then be disseminated in the participating practices and communities over the subsequent 6-month period. The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.
ETHICS AND DISSEMINATION: This study is approved by the Colorado Multiple Institutional Review Board. Results will be disseminated through peer-reviewed manuscripts and conference presentations, as well as within Colorado practice-based research networks.
TRIAL REGISTRATION NUMBER: NCT04279964.

Keywords

Associated Data

ClinicalTrials.gov | NCT04279964

References

  1. J Am Board Fam Med. 2013 May-Jun;26(3):254-63 [PMID: 23657693]
  2. Vaccine. 2014 Jul 16;32(33):4171-8 [PMID: 24886960]
  3. MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):784-92 [PMID: 26225476]
  4. Adm Policy Ment Health. 2012 Jul;39(4):317-20 [PMID: 22240938]
  5. J Am Board Fam Med. 2019 Sep-Oct;32(5):674-684 [PMID: 31506363]
  6. Drugs. 2012 Mar 26;72(5):715-43 [PMID: 22413761]
  7. Qual Health Res. 2012 Apr;22(4):476-87 [PMID: 22068039]
  8. J Pediatr Health Care. 2014 Mar-Apr;28(2):155-64 [PMID: 23522561]
  9. Prev Chronic Dis. 2020 Jan 02;17:E02 [PMID: 31895672]
  10. Ann Fam Med. 2013 Nov-Dec;11(6):500-7 [PMID: 24218373]
  11. J Am Board Fam Med. 2019 Sep-Oct;32(5):655-662 [PMID: 31506361]
  12. Ann Fam Med. 2018 Apr;16(Suppl 1):S58-S64 [PMID: 29632227]
  13. Health Promot Pract. 2015 May;16(3):443-53 [PMID: 25421567]
  14. Hum Vaccin Immunother. 2015;11(2):347-9 [PMID: 25692313]
  15. Health Promot Pract. 2013 Jul;14(4):624-36 [PMID: 23099659]
  16. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723 [PMID: 31437143]
  17. Vaccine. 2012 Nov 20;30 Suppl 5:F157-67 [PMID: 23199959]
  18. Adm Policy Ment Health. 2012 Jul;39(4):301-16 [PMID: 22160786]
  19. Pediatrics. 2013 Jun;131(6):1114-24 [PMID: 23650297]
  20. Arch Pediatr Adolesc Med. 1999 Jan;153(1):9-14 [PMID: 9894993]
  21. J Am Board Fam Med. 2019 Sep-Oct;32(5):663-673 [PMID: 31506362]
  22. Pediatrics. 2012 Mar;129(3):602-5 [PMID: 22371460]
  23. J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23 [PMID: 23104323]
  24. Health Educ Res. 2006 Oct;21(5):688-94 [PMID: 16945984]
  25. Am J Public Health. 1999 Sep;89(9):1322-7 [PMID: 10474547]
  26. Health Aff (Millwood). 2016 Apr;35(4):613-8 [PMID: 27044960]
  27. BMC Public Health. 2009 Aug 10;9:288 [PMID: 19664277]
  28. Front Public Health. 2019 Mar 29;7:64 [PMID: 30984733]
  29. J Am Board Fam Med. 2011 May-Jun;24(3):240-8 [PMID: 21551395]

Grants

  1. R21 CA230878/NCI NIH HHS

MeSH Term

Adolescent
Colorado
Community Participation
Humans
Infant
Papillomavirus Infections
Papillomavirus Vaccines
Parents
Private Practice
Stakeholder Participation
Vaccination

Chemicals

Papillomavirus Vaccines

Word Cloud

Created with Highcharts 10.0.0HPVvaccinepracticesuptakedevelopmentcommunitieswillratecommunityinterventionsBCTinterventionColoradogoalmultifactorialpracticesettingsBootCampTranslationapproachpromoteBCT-designedinitiationANDstudydisseminatedINTRODUCTION:reportstates80%recommendedvaccinesamongadolescentsincludinghumanpapillomavirusHoweverestimated51%2018leavesyoungpeoplevulnerablemorbiditymortalitypreventableHPV-relatedcancersReasonsincludefactorslevelproviderprimarycarepatientfamilyresponsivebarriersreal-worldprioritycommunity-engagedmessagetranslatingevidence-basedclinicsprojectaims1Engage2Evaluateimpactpractice-levelrateshypothesiseincreaseMETHODSANALYSIS:implementHPV-focusedthreecountiesaveragecounty-levelvaccinationgroupdesignmultiprongedtargetedpatientsparentsprovidersgeneralparticipatingsubsequent6-monthperiodlong-termdevelopreplicablelow-costmethodincreasingeasilyadaptabledifferentsociodemographiccontextsETHICSDISSEMINATION:approvedMultipleInstitutionalReviewBoardResultspeer-reviewedmanuscriptsconferencepresentationswellwithinpractice-basedresearchnetworksTRIALREGISTRATIONNUMBER:NCT04279964Engaginguptake:protocolimplementingprivatesettingchildhealthoncologypaediatricinfectiousdisease&immunisationpreventivemedicine

Similar Articles

Cited By